| Not Yet Recruiting | Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Cl NCT07432113 | Federal University of Health Science of Porto Alegre | N/A |
| Not Yet Recruiting | Clinicolaboratory Predictors of Outcome in Children With Encephalitis NCT07241858 | Assiut University | — |
| Active Not Recruiting | Effects of Combined Music Therapy and Occupational Therapy on Motor and Physiological Parameters in Children W NCT07200687 | Armakola Filomeni | N/A |
| Active Not Recruiting | A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine NCT06899802 | Bavarian Nordic | Phase 2 |
| Not Yet Recruiting | Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients NCT06849011 | Yan Zhang | — |
| Recruiting | CoMind Early Feasibility Study NCT06368648 | CoMind Technologies Limited | — |
| Recruiting | Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis) NCT06584045 | Tongji Hospital | N/A |
| Completed | Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Dee NCT06067750 | Nottingham University Hospitals NHS Trust | — |
| Unknown | Improving Diagnosis and Prediction of Outcome in Patients With Severe Disorders of Consciousness NCT06283901 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Enrolling By Invitation | Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis NCT07186881 | Central Hospital, Nancy, France | — |
| Active Not Recruiting | Neuropsychological Rehabilitation Over the Internet NCT05413733 | Helsinki University Central Hospital | N/A |
| Unknown | Regulating Emotions and Behaviors After Brain Injury NCT05393492 | University Hospital, Strasbourg, France | N/A |
| Recruiting | The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis NCT04372615 | University of Utah | Phase 2 |
| Unknown | Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment NCT04946682 | Wen-hong Zhang | N/A |
| Unknown | Establishment of Prevention and Control System of Central Nervous System Infection NCT04722328 | Xuanwu Hospital, Beijing | — |
| Completed | BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally NCT04190303 | University of Liverpool | — |
| Terminated | Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection NCT04361344 | Centre Hospitalier de PAU | N/A |
| Unknown | Neurological Features During COVID19 NCT04460599 | Centre d'Investigation Clinique et Technologique 805 | — |
| Completed | The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumon NCT04325685 | Northern State Medical University | N/A |
| Unknown | Core Cerebrospinal Fluid Biomarker Profile in Anti-Leucine Rich Glioma Inactivated 1 (Anti-LGI1) Encephalitis NCT04001270 | Hospices Civils de Lyon | — |
| Completed | Brazil ICU Encephalitis Surveillance NCT05370573 | D'Or Institute for Research and Education | — |
| Completed | Neurology Inpatient Clinical Education Trial NCT03826056 | Dartmouth-Hitchcock Medical Center | N/A |
| Unknown | Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine NCT03776994 | SRI International | Phase 1 |
| Completed | The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. NCT04323150 | Northern State Medical University | N/A |
| Completed | The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat) NCT03710278 | Spartanburg Regional Healthcare System | — |
| Completed | Epidemiology and Prognosis of Encephalitis in Intensive Care NCT02906631 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | EURopean Study on Encephalitis in Intensive CAre NCT03144570 | ICUREsearch | — |
| Recruiting | Fosfomycin I.v. for Treatment of Severely Infected Patients NCT02979951 | Infectopharm Arzneimittel GmbH | — |
| Completed | Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort NCT02910037 | University of California, San Francisco | N/A |
| Completed | IL-2 in Refractory Autoimmune Encephalitis NCT02714959 | Seoul National University Hospital | Phase 1 / Phase 2 |
| Completed | Neurologic Manifestations of the Arbovirus Infection in Colombia NCT03206541 | Johns Hopkins University | — |
| Completed | Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis NCT02308982 | University of Oxford | Phase 3 |
| Completed | Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab NCT02856451 | Bristol-Myers Squibb | — |
| Recruiting | Central Nervous System Infections in Denmark NCT03418441 | Aalborg University Hospital | — |
| Completed | A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants NCT02367664 | Jiangsu Province Centers for Disease Control and Prevention | Phase 3 |
| Completed | tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis NCT02538094 | Johns Hopkins University | N/A |
| Unknown | SouthEast Asia Encephalitis Project NCT04089436 | Institut Pasteur | — |
| Completed | Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis NCT04080921 | Vinmec Research Institute of Stem Cell and Gene Technology | Phase 1 / Phase 2 |
| Completed | Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed Wit NCT02526550 | Siriraj Hospital | Phase 4 |
| Completed | Nervous System Infections Among Patients With Febrile Seizure NCT01694524 | Hôpital Armand Trousseau | — |
| Completed | A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddler NCT01092507 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Completed | Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population NCT01041573 | Valneva Austria GmbH | Phase 3 |
| Completed | Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Populat NCT01047839 | Valneva Austria GmbH | Phase 3 |
| Completed | Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) NCT01001988 | Sanofi Pasteur, a Sanofi Company | Phase 3 |
| Terminated | Treatment of West Nile Virus With MGAWN1 NCT00927953 | MacroGenics | Phase 2 |
| Completed | Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid NCT00381433 | Sarepta Therapeutics, Inc. | Phase 1 |
| Completed | Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. NCT00314132 | Sanofi | Phase 3 |
| Completed | Natural History of West Nile Virus Infection NCT00069303 | National Institutes of Health Clinical Center (CC) | — |
| Completed | A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults NCT00981175 | Sanofi | Phase 2 |
| Completed | Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir NCT00031486 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | Structure of the Herpes Simplex Virus Receptor NCT00001648 | National Institute of Allergy and Infectious Diseases (NIAID) | — |